JMDC Inc. (TYO:4483)
Japan · Delayed Price · Currency is JPY 4,326.00
-27.00 (-0.62%)
Aug 15, 2025, 3:30 PM JST
JMDC Inc. Revenue
JMDC Inc. had revenue of 10.73B JPY in the quarter ending June 30, 2025, with 27.35% growth. This brings the company's revenue in the last twelve months to 44.35B, up 30.04% year-over-year. In the fiscal year ending March 31, 2025, JMDC Inc. had annual revenue of 41.72B with 28.85% growth.
Revenue (ttm)
44.35B
Revenue Growth
+30.04%
P/S Ratio
6.38
Revenue / Employee
20.28M
Employees
2,187
Market Cap
282.83B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 41.72B | 9.34B | 28.85% |
| Mar 31, 2024 | 32.38B | 4.57B | 16.44% |
| Mar 31, 2023 | 27.81B | 6.00B | 27.48% |
| Mar 31, 2022 | 21.81B | 5.04B | 30.07% |
| Mar 31, 2021 | 16.77B | 4.61B | 37.94% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,196.22B |
| Takeda Pharmaceutical Company | 4,480.25B |
| Daiichi Sankyo Company | 1,924.68B |
| HOYA Corporation | 876.09B |
| Otsuka Holdings | 2,401.70B |
| Terumo | 1,037.94B |
| Astellas Pharma | 1,944.99B |
| Shionogi & | 440.50B |